DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Herceptin (Trastuzumab) - Death - Suspected Cause - Side Effect Reports

 
 



Index of reports > Death (260)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Herceptin (Trastuzumab) death. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 260   Next >>

Possible Herceptin side effects in 54 year old male

Reported by a physician from Brazil on 2012-08-27

Patient: 54 year old male

Reactions: Disease Progression

Adverse event resulted in: death

Drug(s) suspected as cause:
Xeloda
    Indication: Metastatic Gastric Cancer
    Start date: 2009-03-18

Herceptin
    Indication: Metastatic Gastric Cancer

Oxaliplatin
    Indication: Metastatic Gastric Cancer
    Start date: 2009-03-18



Possible Herceptin side effects in female

Reported by a physician from United States on 2012-08-27

Patient: female

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Herceptin



Possible Herceptin side effects in female

Reported by a consumer/non-health professional from Ecuador on 2012-08-20

Patient: female

Reactions: Pneumonia

Adverse event resulted in: death

Drug(s) suspected as cause:
Herceptin



Possible Herceptin side effects in female

Reported by a physician from United States on 2012-08-17

Patient: female, weighing 57.3 kg (126.1 pounds)

Reactions: Haemorrhage Intracranial, Sepsis, Hypotension, Pneumonia Streptococcal, Failure To Thrive, Acute Respiratory Failure, Convulsion

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Paclitaxel
    Dosage: last dose prior to sae: 09/mar/2012
    Indication: Breast Cancer Metastatic

Herceptin
    Dosage: last dose prior to sae 09/mar/2012, last dose taken: 344 mg
    Indication: Breast Cancer Metastatic
    Start date: 2012-01-06

Docetaxel
    Dosage: last dose prior to sae 09/mar/2012, last dose taken: 167 mg
    Indication: Breast Cancer Metastatic
    Start date: 2012-01-06

Other drugs received by patient: Naproxen; Dexamethasone; Zometa; Dextrose; Ativan; Diphenhydramine HCL; Neulasta; Lortab; Robaxin; Fosphenytoin Sodium; Ciprofloxacin; Magnesium Sulfate; Lasix; Ferrous Sulfate TAB; Remeron; Artificial Tears; Amlodipine Besylate; Benadryl; Hydrocodone; Celexa; Acetaminophen; Lorazepam; Phenergan HCL; Potassium Chloride; Hydrocodone Bitartrate + Acetaminophen; Protonix; Aloxi; Mineral OIL; Insulin Aspart; Morphine Sulfate; Zofran; Cocaine; Udderly Smooth Cream



Possible Herceptin side effects in male

Reported by a physician from Korea, Republic of on 2012-08-16

Patient: male, weighing 55.0 kg (121.0 pounds)

Reactions: Pneumonia Fungal, Fatigue, Renal Failure Acute

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Xeloda
    Dosage: date of most recent dose prior to sae: 31/jan/2012
    Administration route: Oral
    Indication: Gastric Cancer
    Start date: 2011-12-21

Herceptin
    Dosage: date of most recent dose prior to sae: 18/jan/2012, 330 mg
    Indication: Gastric Cancer
    Start date: 2011-12-21

Pertuzumab
    Dosage: date of most recent dose prior to sae: 18/jan/2012, 840 mg
    Indication: Gastric Cancer
    Start date: 2011-12-21

Cisplatin
    Dosage: date of most recent dose prior to sae: 18/jan/2012
    Indication: Gastric Cancer
    Start date: 2011-12-21

Other drugs received by patient: Ramosetron; Artemisia Asiatica; Potassium Phosphate, Monobasic; Potassium Phosphate, Monobasic; Tramadol HCL; Albumin; Pethidine HCL; Phytonadione; Tranexamic Acid; Potassium Chloride; Potassium Phosphate, Monobasic; Albumin; Fresh Frozen Plasma; Tetracosactrin; Aprepitant; Dexamethasone; Loperamide Oxide; Megestrol Acetate; Potassium Chloride; Potassium Chloride; Potassium Phosphate, Monobasic; Albumin; Dihydrocodeine Bitartrate INJ; Methylprednisolone Sodium Succinate; Ramosetron; Lactobacillus Acidophilus; Joulie's Solution; Potassium Phosphate, Monobasic; Esomeprazole; Esomeprazole; RED Blood Cells; Aprepitant; Chlorpheniramine Maleate; Ranitidine; Ultracet; Potassium Chloride; Esomeprazole; Pethidine HCL; Remifentanil; Famotidine; Potassium Phosphate, Monobasic; Lenograstim; Bisacodyl; Magnesium Sulfate; Sodium Bicarbonate; Potassium Phosphate, Monobasic; Esomeprazole; Tramadol HCL; Albumin; Morphine HCL; Chlorpheniramine Maleate; Pethidine HCL; Dexamethasone; Potassium Chloride; Potassium Chloride; Potassium Phosphate, Monobasic; Potassium Phosphate, Monobasic; Potassium Phosphate, Monobasic; Fresh Frozen Plasma; Ketoprofen; Fentanyl Citrate



Possible Herceptin side effects in female

Reported by a physician from United States on 2012-08-16

Patient: female, weighing 57.3 kg (126.1 pounds)

Reactions: Sepsis, Pneumonia Streptococcal, Hypotension, Haemorrhage Intracranial, Acute Respiratory Failure, Failure To Thrive, Convulsion

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Docetaxel
    Dosage: last dose prior to sae 09/mar/2012, last dose taken: 167 mg
    Indication: Breast Cancer Metastatic
    Start date: 2012-01-06

Paclitaxel
    Dosage: last dose prior to sae: 09/mar/2012
    Indication: Breast Cancer Metastatic

Herceptin
    Dosage: last dose prior to sae 09/mar/2012, last dose taken: 344 mg
    Indication: Breast Cancer Metastatic
    Start date: 2012-01-06

Other drugs received by patient: Dexamethasone; Protonix; Zosyn; Insulin Aspart; Udderly Smooth Cream; Benadryl; Naproxen; Celexa; Aloxi; Diphenhydramine HCL; Zometa; Phenergan HCL; Acetaminophen; Fosphenytoin Sodium; Lortab; Lorazepam; Cocaine; Potassium Chloride; Ceftriaxone; Mineral OIL; Lasix; Levophed; Ferrous Sulfate TAB; Ciprofloxacin; Dextrose; Vancomycin HCL; Ativan; Neulasta; Robaxin; Artificial Tears; Hydrocodone; Remeron; Zofran; Hydrocodone Bitartrate + Acetaminophen; Magnesium Sulfate; Phenytoin Sodium



Possible Herceptin side effects in female

Reported by a physician from Philippines on 2012-08-13

Patient: female, weighing 56.2 kg (123.6 pounds)

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Herceptin
    Indication: Breast Cancer
    Start date: 2011-07-21

Cyclophosphamide
    Indication: Breast Cancer
    Start date: 2010-11-04

Herceptin

Epirubicin Hydrochloride
    Indication: Breast Cancer
    Start date: 2010-11-04

Docetaxel
    Indication: Breast Cancer
    Start date: 2010-09-02

Fluorouracil
    Indication: Breast Cancer
    Start date: 2010-11-04



Possible Herceptin side effects in female

Reported by a physician from United States on 2012-08-08

Patient: female

Reactions: Metastases To Liver

Adverse event resulted in: death

Drug(s) suspected as cause:
Avastin
    Indication: Breast Cancer Female
    Start date: 2005-12-01

Herceptin
    Indication: Product Used FOR Unknown Indication

Avastin

Other drugs received by patient: Tamoxifen Citrate; Cytoxan; Mitoxantrone; Taxotere; Taxol; Leucovorin Calcium; Fluorouracil; Adriamycin PFS



Possible Herceptin side effects in female

Reported by a physician from Japan on 2012-08-08

Patient: female, weighing 52.0 kg (114.4 pounds)

Reactions: Interstitial Lung Disease, Cardiac Failure, Cerebral Infarction, Disseminated Intravascular Coagulation

Adverse event resulted in: death

Drug(s) suspected as cause:
Herceptin
    Dosage: dose lowered
    Start date: 2010-07-09
    End date: 2010-07-09

Cyclophosphamide
    Dosage: doseage is uncertain
    Indication: Breast Cancer
    Start date: 2010-02-05
    End date: 2010-04-09

Taxotere
    Dosage: dose is uncertain
    Indication: Breast Cancer
    Start date: 2010-05-07
    End date: 2010-07-09

Herceptin
    Start date: 2010-05-28
    End date: 2010-05-28

Herceptin
    Start date: 2010-06-18
    End date: 2010-06-18

Herceptin
    Indication: Breast Cancer
    Start date: 2010-05-07
    End date: 2010-05-07

Other drugs received by patient: Fluorouracil; Epirubicin Hydrochloride; Betamethasone; Sulpiride; Sulpiride; Prochlorperazine; Betamethasone; Prochlorperazine; Sulpiride; Betamethasone; Sulpiride; Prochlorperazine; Betamethasone; Prochlorperazine



Possible Herceptin side effects in female

Reported by a physician from Japan on 2012-08-07

Patient: female, weighing 55.0 kg (121.0 pounds)

Reactions: Pneumonia, Respiratory Failure, Pneumomediastinum, Pneumothorax

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Herceptin
    Start date: 2012-02-13
    End date: 2012-04-16

Herceptin
    Indication: Breast Cancer
    Start date: 2012-01-23
    End date: 2012-01-23

Other drugs received by patient: Taxotere; Granisetron; Dexamethasone Sodium Phosphate; Mucosta; Motilium; Ramelteon



Possible Herceptin side effects in female

Reported by a physician from United States on 2012-08-07

Patient: female, weighing 69.9 kg (153.8 pounds)

Reactions: Urinary Tract Infection, Bacterial Sepsis, Abscess, Peritonitis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Herceptin
    Dosage: 140 mg
    End date: 2011-08-10

Carboplatin
    Dosage: 792 mg
    End date: 2011-08-10

Taxotere
    Dosage: 130 mg
    End date: 2011-08-10



Possible Herceptin side effects in female

Reported by a physician from Philippines on 2012-08-03

Patient: female, weighing 52.0 kg (114.4 pounds)

Reactions: Gastrointestinal Ulcer, Cardio-Respiratory Arrest, Pneumonia, Febrile Neutropenia, Duodenal Ulcer, Hepatic Failure, Neutropenia

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Docetaxel
    Dosage: dose level:100 mg/m2; last dose prior to sae 26 oct 2010, permanently discontinued on 16 nov 2010
    Indication: Breast Cancer
    Start date: 2010-10-26
    End date: 2010-11-16

Herceptin
    Dosage: last dose prior to sae : 26 oct 2010, permanently discontinued on 16 nov 2010
    Indication: Breast Cancer
    Start date: 2010-10-26
    End date: 2010-11-16

Other drugs received by patient: Mucosta; Fluconazole; Acetaminophen; Tinzaparin; Tranexamic Acid; Omeprazole; Ciprofloxacin; Vitamin K TAB



Possible Herceptin side effects in 48 year old male

Reported by a physician from Germany on 2012-08-02

Patient: 48 year old male, weighing 85.0 kg (187.0 pounds)

Reactions: Agranulocytosis, Neoplasm Malignant, Neutropenia, Upper Gastrointestinal Haemorrhage, Skin Infection

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Herceptin

Other drugs received by patient: Fluorouracil; Docetaxel; Cisplatin



Possible Herceptin side effects in female

Reported by a physician from Philippines on 2012-08-01

Patient: female, weighing 56.2 kg (123.6 pounds)

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Herceptin
    Indication: Breast Cancer
    Start date: 2011-07-21

Fluorouracil
    Indication: Breast Cancer
    Start date: 2010-11-04

Epirubicin Hydrochloride
    Indication: Breast Cancer
    Start date: 2010-11-04

Herceptin

Docetaxel
    Indication: Breast Cancer
    Start date: 2010-09-02

Cyclophosphamide
    Indication: Breast Cancer
    Start date: 2010-11-04



Possible Herceptin side effects in female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-08-01

Patient: female

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Herceptin



Possible Herceptin side effects in female

Reported by a physician from Spain on 2012-07-31

Patient: female, weighing 74.0 kg (162.8 pounds)

Reactions: Pulmonary Toxicity, Organising Pneumonia, Respiratory Failure

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Vinorelbine
    Indication: Breast Cancer Metastatic
    Start date: 2012-03-29
    End date: 2012-03-29

Herceptin
    Indication: Breast Cancer Metastatic
    Start date: 2012-02-16
    End date: 2012-03-01

Herceptin
    Start date: 2012-03-29
    End date: 2012-03-29

Taxol
    Indication: Breast Cancer Metastatic
    Start date: 2012-01-25
    End date: 2012-03-01



Possible Herceptin side effects in 82 year old

Reported by a physician from Japan on 2012-07-30

Patient: 82 year old

Reactions: Stomatitis, Rash, Neutrophil Count Decreased, Renal Failure Acute

Adverse event resulted in: death

Drug(s) suspected as cause:
Herceptin
    Dosage: dosage is uncertain.
    Indication: Gastric Cancer Recurrent

Xeloda
    Dosage: dosage is uncertain.
    Administration route: Oral
    Indication: Gastric Cancer Recurrent

Other drugs received by patient: Cisplatin



Possible Herceptin side effects in female

Reported by a physician from Spain on 2012-07-30

Patient: female, weighing 57.0 kg (125.4 pounds)

Reactions: non-Cardiogenic Pulmonary Oedema, Respiratory Failure

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Carboplatin
    Indication: Breast Cancer Metastatic
    Start date: 2012-06-08
    End date: 2012-06-08

Herceptin
    Indication: Breast Cancer Metastatic
    Start date: 2012-06-08
    End date: 2012-06-08

Zoledronic Acid
    Indication: Breast Cancer Metastatic
    Start date: 2012-04-27

Herceptin
    Start date: 2012-04-27



Possible Herceptin side effects in female

Reported by a physician from United States on 2012-07-27

Patient: female

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Herceptin

Other drugs received by patient: Gentamicin; Fluracil; Cytoxan; Methotrexate



Possible Herceptin side effects in female

Reported by a physician from Germany on 2012-07-26

Patient: female

Reactions: Myocardial Infarction

Adverse event resulted in: death

Drug(s) suspected as cause:
Herceptin



Possible Herceptin side effects in female

Reported by a consumer/non-health professional from United States on 2012-07-26

Patient: female

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Herceptin
    Indication: Product Used FOR Unknown Indication

Xeloda
    Indication: Product Used FOR Unknown Indication



Possible Herceptin side effects in 51 year old female

Reported by a pharmacist from United States on 2012-07-24

Patient: 51 year old female

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Taxotere
    Indication: Product Used FOR Unknown Indication

Perjeta
    Indication: Product Used FOR Unknown Indication

Taxotere

Herceptin
    Indication: Product Used FOR Unknown Indication

Taxotere



Possible Herceptin side effects in female

Reported by a physician from Spain on 2012-07-24

Patient: female

Reactions: Pulmonary Toxicity, Respiratory Failure

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Taxol
    Indication: Breast Cancer Metastatic

Vinorelbine
    Indication: Breast Cancer Metastatic

Herceptin
    Indication: Breast Cancer Metastatic



Possible Herceptin side effects in female

Reported by a physician from Spain on 2012-07-24

Patient: female

Reactions: Respiratory Failure

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Carboplatin
    Indication: Breast Cancer Metastatic

Herceptin
    Indication: Breast Cancer Metastatic



Possible Herceptin side effects in male

Reported by a physician from United States on 2012-07-24

Patient: male

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Herceptin
    Dosage: 450 mg, unknown/d
    Indication: Product Used FOR Unknown Indication

Tarceva
    Dosage: unk
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication



Possible Herceptin side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-23

Patient: male

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Herceptin



Possible Herceptin side effects in female

Reported by a physician from United States on 2012-07-19

Patient: female, weighing 57.3 kg (126.1 pounds)

Reactions: Pneumonia Streptococcal, Sepsis, Haemorrhage Intracranial, Hypotension, Acute Respiratory Failure, Failure To Thrive, Convulsion

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Paclitaxel
    Dosage: last dose prior to sae: 09/mar/2012
    Indication: Breast Cancer Metastatic

Docetaxel
    Dosage: last dose prior to sae 09/mar/2012, last dose taken: 167 mg
    Indication: Breast Cancer Metastatic
    Start date: 2012-01-06

Herceptin
    Dosage: last dose prior to sae 09/mar/2012, last dose taken: 344 mg
    Indication: Breast Cancer Metastatic
    Start date: 2012-01-06



Possible Herceptin side effects in 52 year old female

Reported by a physician from France on 2012-07-18

Patient: 52 year old female

Reactions: Intracranial Pressure Increased

Adverse event resulted in: death

Drug(s) suspected as cause:
Herceptin
    Indication: Breast Cancer

Vinorelbine Tartrate
    Indication: Breast Cancer



Possible Herceptin side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-17

Patient: female

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Herceptin



Possible Herceptin side effects in female

Reported by a physician from United States on 2012-07-17

Patient: female, weighing 57.3 kg (126.1 pounds)

Reactions: Hypotension, Sepsis, Haemorrhage Intracranial, Pneumonia Streptococcal, Acute Respiratory Failure, Failure To Thrive, Convulsion

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Paclitaxel
    Dosage: last dose prior to sae: 09/mar/2012
    Indication: Breast Cancer Metastatic

Docetaxel
    Dosage: last dose prior to sae 09/mar/2012, last dose taken: 167 mg
    Indication: Breast Cancer Metastatic
    Start date: 2012-01-06

Herceptin
    Dosage: last dose prior to sae 09/mar/2012, last dose taken: 344 mg
    Indication: Breast Cancer Metastatic
    Start date: 2012-01-06



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017